Krystal Biotech (KRYS) Total Debt (2016)
Krystal Biotech (KRYS) posted quarterly Total Debt of $698000.0 for Q4 2016.
Krystal Biotech (KRYS) Total Debt (2016) Analysis & Trends
Krystal Biotech has reported Total Debt for 1 years, with the latest figure at $698000.0 in Q4 2016.
- Total Debt for Q4 2016 came in at $698000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2016 was $698000.0 (changed N/A YoY), and the FY2016 annual result was $698000.0, changed N/A from the prior year.
- Total Debt held at $698000.0 in Q4 2016.
- Over five years, Total Debt peaked at $698000.0 in Q4 2016 and troughed at $698000.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Krystal Biotech | 9.83 Bn | 8.99 Bn | 112.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 698,000.00 |